Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

DiNardo

Showing results (721-730 of 1,482) with videos related to

Pageof 149
Sort By:
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|January 26, 2020
Effectiveness of strategies to screen for blood donors with RH variants in a mixed populationFabio Augusto Abreu de Almeida, Marcia Regina Dezan, Valeria Brito Oliveira, et al.
Transfusion|March 9, 2021
Variant genotypes associated with reduced expression of RhCE antigens among Brazilian blood donorsMarcia Regina Dezan, Valéria B Oliveira, Marina C A V Conrado, et al.
Frontiers in Plant Science|July 2, 2025
Effects of thiamethoxam insecticide on sugarcane plant growth under chemical ripening at early and late harvestDeise de Paula Silva, Josiane Viveiros, Lucas Moraes Jacomassi, et al.
Allergy|September 16, 2024
Omalizumab reduces anaphylactic reactions and allows food introduction in food-allergic in children with severe asthma: An observational studyStefania Arasi, Arianna Cafarotti, Francesca Galletta, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 27, 2025
Histamine H1 Receptor: A potential therapeutic target for pancreatic ductal adenocarcinomaCristina Salmerón, Elena Tomás Bort, Krishna Sriram, et al.
Genes|January 21, 2022
Quality of Life Scores Remained Different among the Genotypic Groups of Patients with Suspected Hemochromatosis, Even after Treatment PeriodLuis Alfredo Utria Acevedo, Aline Morgan Alvarenga, Paula Fernanda Silva Fonseca, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 13, 2022
Long-Term Outcomes among Adolescent and Young Adult Survivors of Acute Leukemia: A Surveillance, Epidemiology, and End Results AnalysisAmy M Berkman, Clark R Andersen, Branko Cuglievan, et al.
Leukemia & Lymphoma|July 16, 2020
Consensus minimum hemoglobin level above which patients with myelodysplastic syndromes can safely forgo transfusionsAnna M Tanasijevic, Anna Revette, Heidi D Klepin, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|April 29, 2022
Impact of HLA-G +3142C>G on the development of antibodies to blood group systems other than the Rh and Kell among sensitized patients with sickle cell diseaseJuliana O Martins, Flavia Pagani, Marcia R Dezan, et al.
American Journal of Hematology|September 2, 2022
Retrospective comparison of survival and responses to Fludarabine, Cytarabine, GCSF (FLAG) in combination with gemtuzumab ozogamicin (GO) or Idarubicin (IDA) in patients with newly diagnosed core binding factor (CBF) acute myelogenous leukemia: MD Anderson experience in 174 patientsGautam Borthakur, Farhad Ravandi, Keyur Patel, et al.
Pageof 149

Showing results (721-730 of 1,482) with videos related to

Sort By:
Pageof 149
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|January 26, 2020
Effectiveness of strategies to screen for blood donors with RH variants in a mixed populationFabio Augusto Abreu de Almeida, Marcia Regina Dezan, Valeria Brito Oliveira, et al.
Transfusion|March 9, 2021
Variant genotypes associated with reduced expression of RhCE antigens among Brazilian blood donorsMarcia Regina Dezan, Valéria B Oliveira, Marina C A V Conrado, et al.
Frontiers in Plant Science|July 2, 2025
Effects of thiamethoxam insecticide on sugarcane plant growth under chemical ripening at early and late harvestDeise de Paula Silva, Josiane Viveiros, Lucas Moraes Jacomassi, et al.
Allergy|September 16, 2024
Omalizumab reduces anaphylactic reactions and allows food introduction in food-allergic in children with severe asthma: An observational studyStefania Arasi, Arianna Cafarotti, Francesca Galletta, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 27, 2025
Histamine H1 Receptor: A potential therapeutic target for pancreatic ductal adenocarcinomaCristina Salmerón, Elena Tomás Bort, Krishna Sriram, et al.
Genes|January 21, 2022
Quality of Life Scores Remained Different among the Genotypic Groups of Patients with Suspected Hemochromatosis, Even after Treatment PeriodLuis Alfredo Utria Acevedo, Aline Morgan Alvarenga, Paula Fernanda Silva Fonseca, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 13, 2022
Long-Term Outcomes among Adolescent and Young Adult Survivors of Acute Leukemia: A Surveillance, Epidemiology, and End Results AnalysisAmy M Berkman, Clark R Andersen, Branko Cuglievan, et al.
Leukemia & Lymphoma|July 16, 2020
Consensus minimum hemoglobin level above which patients with myelodysplastic syndromes can safely forgo transfusionsAnna M Tanasijevic, Anna Revette, Heidi D Klepin, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|April 29, 2022
Impact of HLA-G +3142C>G on the development of antibodies to blood group systems other than the Rh and Kell among sensitized patients with sickle cell diseaseJuliana O Martins, Flavia Pagani, Marcia R Dezan, et al.
American Journal of Hematology|September 2, 2022
Retrospective comparison of survival and responses to Fludarabine, Cytarabine, GCSF (FLAG) in combination with gemtuzumab ozogamicin (GO) or Idarubicin (IDA) in patients with newly diagnosed core binding factor (CBF) acute myelogenous leukemia: MD Anderson experience in 174 patientsGautam Borthakur, Farhad Ravandi, Keyur Patel, et al.
Pageof 149